We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KZR
1051
DELISTED
Kezar Life Sciences
KZR
$209K 0.03%
+2,533
New +$223K
LIAN
1052
DELISTED
LianBio American Depositary Shares
LIAN
$209K 0.03%
+96,584
New +$328K
FBIN icon
1053
Fortune Brands Innovations
FBIN
$6.06B
$208K 0.03%
4,066
-2,209
-35% -$129K
ONEM
1054
DELISTED
1Life Healthcare
ONEM
$208K 0.03%
+26,506
New +$228K
ELF icon
1055
e.l.f. Beauty
ELF
$5.81B
$207K 0.03%
+6,738
New +$169K
DICE
1056
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$207K 0.03%
+13,325
New +$229K
NBP
1057
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$206K 0.03%
18,195
+486
+3% +$5.83K
WTS icon
1058
Watts Water Technologies
WTS
$13.1B
$206K 0.03%
1,679
-862
-34% -$112K
MRNS
1059
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$205K 0.03%
42,256
-23,273
-36% -$142K
IONS icon
1060
Ionis Pharmaceuticals
IONS
$9.4B
$203K 0.03%
+5,475
New +$206K
RAPT
1061
DELISTED
RAPT Therapeutics
RAPT
$203K 0.03%
1,390
-974
-41% -$130K
COHU icon
1062
Cohu
COHU
$2.5B
$202K 0.03%
+7,272
New +$201K
CW icon
1063
Curtiss-Wright
CW
$25.5B
$202K 0.03%
+1,533
New +$218K
MCHB
1064
Mechanics Bancorp
MCHB
$3.68B
$202K 0.03%
+5,839
New +$235K
INSP icon
1065
Inspire Medical Systems
INSP
$1.74B
$202K 0.03%
+1,107
New +$221K
ARW icon
1066
Arrow Electronics
ARW
$10.4B
$201K 0.03%
+1,797
New +$210K
MTLS
1067
Materialise
MTLS
$396M
$201K 0.03%
14,734
-1,221
-8% -$19.3K
TXRH icon
1068
Texas Roadhouse
TXRH
$13.7B
$201K 0.03%
2,746
-2,852
-51% -$224K
AGX icon
1069
Argan
AGX
$8.37B
$200K 0.03%
+5,361
New +$205K
JBLU icon
1070
JetBlue
JBLU
$2.29B
$200K 0.03%
23,950
-8,956
-27% -$95.7K
SSTI icon
1071
SoundThinking
SSTI
$103M
$200K 0.03%
+7,445
New +$208K
ALBO
1072
DELISTED
Albireo Pharma Inc
ALBO
$200K 0.03%
+10,079
New +$266K
PRTS icon
1073
CarParts.com
PRTS
$54.7M
$198K 0.03%
+2,848
New +$208K
ADPT icon
1074
Adaptive Biotechnologies
ADPT
$3.97B
$196K 0.03%
+24,245
New +$213K
EZPW icon
1075
Ezcorp Inc
EZPW
$1.71B
$196K 0.03%
26,037
-89,022
-77% -$648K

Similar funds

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.